ArticlemedRxiv : the preprint server for health sciences2023

Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients.

Tesa M Severson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.